The US Food and Drug Administration has issued its first approval for a drug to treat lipodystrophy, a condition in which excess fat develops in different areas of the body, most notably around the liver, stomach and other abdominal areas. ---Subscribe to MedNous to access this article--- Regulation & Policy
